The dependency has been attributed to the French during Coronavirus-crisis abruptly in front of eyes. Whether masks, virus, tests, or the chemical ingredients of medications – much is no longer manufactured in France. Therefore, Paris blows a big return action. As the first large icon, the government wants to bring back the production of the medicinal product-active substance, Paracetamol, within three years, in the home. This provides for a Plan by the French ministries of economy and health on Thursday in Paris have presented.
economic correspondent in Paris.
The project falls in line with the since the Coronavirus-crisis reinforced efforts of the President and Emmanuel Macron, particularly in the health and pharmaceutical area, more industrial self-sufficiency. France wants to according to the plans, especially with the French pharmaceutical company Sanofi, Seqens and Upsazusammenarbeiten. Paracetamol is produced according to a Seqens Manager since 2008 in France. 50 percent of the global production capacity are today, in China, 30 percent in India.
Sanofi had announced before the Covid-19-crisis, the business with chemical agents in a separate company to outsource and bring them under circumstances in 2022, at the stock exchange. The pain medication Doliprane, which contains Paracetamol, is one of the drugs produced by Sanofi. During the crisis, the pharmaceutical manufacturer has increased the production. Other than fear, there was no scarcity.Date Of Update: 19 June 2020, 13:20